Buprenorphine Diversion and Misuse: How to Protect Your Office-based Opioid Addiction Practice
|
Upon completion of this activity, participants should be able to: - Summarize the Drug Abuse Treatment Act (DATA) of 2000;
- Explain how controlled drug scheduling status affects office-based treatment of opioid dependence (OBOT);
- Define diversion and misuse;
- Describe motives for diversion and misuse.
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 0.25
-
Type: Video Webcast
- Expires: Aug 23, 2012
- Cost: Free
|
|
Upon completion of this activity, participants should be able to: - List one way to decrease chances that a “pseudopatient” would enter your practice;
- List treatment practices that patients can be informed of over the phone;
- List recommended frequency of initial visits;
- Describe current dosing recommendations for in-office induction;
- Describe three roles of the pharmacist;
- Identify role of a patient-designated support person.
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 1.00
-
Type: Video Webcast
- Expires: Aug 23, 2012
- Cost: Free
|
|
Upon completion of this activity, participants should be able to: - Review the pharmacological properties of buprenorphine;
- Discuss the dose guidelines and their pharmacological rationale;
- Recognize dosing/prescribing practices that inadvertently support diversion.
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 0.50
-
Type: Video Webcast
- Expires: Aug 23, 2012
- Cost: Free
|
|
Upon completion of this activity, participants should be able to: - Name three objective outcomes to monitor;
- Describe how to use urine drug screens, pill counts and pharmacies, state prescription monitoring programs, appointment adherence, and counseling/12 step programs in OBOT;
- Explain how psychosocial and behavioral treatments may minimize diversion and misuse;
- Explain how psychosocial and behavioral treatments can be integrated into OBOT;
- Explain how office staff may help reduce risk of diversion and misuse;
- Explain how to access the Physician Clinical Support System (PCSS-B) and what it does.
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 1.75
-
Type: Video Webcast
- Expires: Aug 23, 2012
- Cost: Free
|
|
Upon completion of this activity, participants should be able to: - Describe what to do when a patient is not adhering to treatment recommendations and continues to test positive for opioids and/or other illicit drugs such as benzodiazepines;
- Explain the overall role of buprenorphine in the treatment of opioid addiction.
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 0.50
-
Type: Video Webcast
- Expires: Aug 23, 2012
- Cost: Free
|
|
|
|
E-mail
Begin